INVASIVE ASPERGILLOSIS
Clinical trials for INVASIVE ASPERGILLOSIS explained in plain language.
Never miss a new study
Get alerted when new INVASIVE ASPERGILLOSIS trials appear
Sign up with your email to follow new studies for INVASIVE ASPERGILLOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a gentler antifungal drug protect liver transplant patients from deadly mold without risking organ rejection?
Disease control Not yet recruitingInvasive mold infections are a major threat to liver transplant recipients, with mortality rates as high as 90%. The standard treatment, voriconazole, can interfere with anti-rejection drugs, increasing the risk of graft loss. This trial tests whether liposomal amphotericin B (Am…
Matched conditions: INVASIVE ASPERGILLOSIS
Phase: NA • Sponsor: Beijing Friendship Hospital • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a cancer drug wake up immune cells to beat HIV-Related infections?
Disease control Not yet recruitingThis study tests a drug called Sintilimab, which is normally used for cancer, to see if it can help people with HIV who have infections that won't go away with standard treatment. The drug works by 'waking up' exhausted immune cells. Fifty adults with HIV and a hard-to-treat infe…
Matched conditions: INVASIVE ASPERGILLOSIS
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Public Health Clinical Center • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC